Apollo Hospitals Delhi Q3 PAT up 25% YoY to Rs 41 cr; board updates
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indraprastha Apollo Hospitals posted Q3 FY26 revenue of Rs 371.6 cr, up 14% YoY, with PAT rising about 25% YoY to Rs 41 cr. For 9M FY26, revenue grew 9% to Rs 1,118 cr and PAT rose 18% to Rs 142 cr. Board noted a fresh affidavit from Delhi Govt in the pending Supreme Court case on the Sarita Vihar hospital land lease. One new independent director was appointed and three were re-appointed for 5-year terms.
Strong Q3 profit growth is positive; ongoing Supreme Court case on land lease remains a key overhang for shareholders.